Fragile bones and weak muscles take center stage at IOF-ESCEO World Congress in Florence

March 23, 2017

Florence, Italy - March 23, 2017 Researchers and clinicians from all regions of the world will be gathering in Florence, Italy today for the opening of the World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO Florence 2017), which continues until March 26, 2017 at the Fortezza da Basso Congress center. As the largest scientific event devoted to musculoskeletal disorders, the annual Congress is hosted by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

The more than 4000 international delegates expected include researchers, clinicians, and key opinion leaders across a range of specializations, including, among others, endocrinology, rheumatology, orthopaedics and gerontology. The IOF Worldwide Conference of Osteoporosis Patient Societies will be held in conjunction with the scientific Congress, drawing more than 100 patient society representatives to Florence.

Professor Jean-Yves Reginster, Congress Co-chair and ESCEO President, commented: "We're delighted to see the Congress move from strength to strength, as there has been yet another record breaking year in terms of abstract submissions and growth in the number of attendees from around the world. With more than 1430 abstracts submitted, our delegates will be able to view an abundance of exciting research presented in both oral and poster presentations. As well as being a forum for new advances in osteoporosis and osteoarthritis, the Congress has a strong focus on frailty and sarcopenia, disorders which are a major cause of functional disability and falls leading to fractures. Given the ageing of the population, better knowledge of these conditions is urgently required and I am delighted that the Congress has become a key forum for this emerging research area."

WCO-IOF-ESCEO 2017 has been chosen as the venue for the launch of the Integrated Care for Older People (ICOPE) Guidelines by the World Health Organization (WHO), in a dedicated session on March 24th. Dr John R. Beard (Director of the Department of Ageing and Life Course, WHO, Geneva) will Chair the session as well as present an opening keynote lecture on WHO's new approach to Healthy Ageing and its implications for research and clinical practice. A keynote lecture will also be held by the European Medicines Agency, with Dr Francesca Cerreta presenting on the baseline stratification of patients on the basis of frailty, and the CHMP pilot on geriatric assessment.

Granted 15 European CME credits by the EACCME, the Congress will include 15 non-sponsored symposia, 10 plenary lectures, nine Meet-the-Expert sessions, seven topical symposia, nine industry-sponsored symposia, three educational lectures, two honorary lectures, and two poster viewing sessions. A complete programme overview is available at http://www.wco-iof-esceo.org/thursday-23

IOF President John A. Kanis stated: "I'd like to thank the Scientific Programme Committee, headed by René Rizzoli (ESCEO) and Cyrus Cooper (IOF), who have put together a diverse and relevant programme that will engage both clinicians seeking to advance their clinical knowledge and investigators eager to hear about new directions in research. It is gratifying to see that the Congress continues to build on its reputation as a key platform for the communication of new developments in clinical care and a forum of choice for the presentation of new research."
-end-
World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Florence 2017):

Held jointly by IOF and ESCEO, the Congress takes place in Florence, Italy, from March 23-26, 2017. WCO-IOF-ESCEO is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF:

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 237 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. http://www.iofbonehealth.orghttp://www.facebook.com/@iofbonehealth

About ESCEO:

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.